Tsuchiya, Y., Nakajima, M
Fast and safe delivery 1) The package c Hebei Dangtong Biological Technology Co.,LTD was established in August 2021
Mokhtari V, Afsharian P, Shahhoseini M, et al
Industry Response: The compounding pharmacy industry, medical practitioners, and patient advocacy groups pushed back against the Category 2 classification, arguing that the safety data did not support such a restrictive designation
Experiments carried out on cells cultured in vitro have shown that both bilirubin and biliverdin are endogenous agonists of the AhR (97)
Funding The work was sponsored by the National Natural Science Foundation of China (31802208) and the Science and Technology Research Project of Education Department of Hubei Province (Q20221302)